Table 1.
Baseline Patient Demographics.
| Variables | Patients (n = 44) |
|---|---|
| Age, years | 65 (45-81) |
| Sex | |
| Male | 31 (70.5) |
| Female | 13 (29.5) |
| BMI, kg/m2 | 23.3 (17.2-30.5) |
| ASA score | |
| 1 | 7 (15.9) |
| 2 | 35 (79.5) |
| Unknown | 2 (4.5) |
| Underlying disease | |
| Diabetes | 7 (15.9) |
| Pulmonary disease | 7 (15.9) |
| Cardiovascular disease | 25 (56.8) |
| Primary tumor site | |
| Colon | 31 (70.5) |
| Rectum | 13 (29.5) |
| Metastatic site | |
| Liver only | 20 (45.5) |
| Lung only | 6 (13.6) |
| Liver and lung | 12 (27.3) |
| Others | 6 (13.6) |
| Metastatic status on first-line chemotherapy | |
| Synchronous | 32 (72.7) |
| Metachronous | 12 (27.3) |
| Resection of primary tumor a | |
| Yes | 30 (93.8) |
| No | 2 (6.2) |
| K-RAS status | |
| Wild-type | 23 (52.3) |
| Mutant-type | 18 (40.9) |
| Unknown | 3 (6.8) |
| MSI status | |
| MSS | 38 (86.4) |
| MSI-L | 2 (4.5) |
| Unknown | 4 (9.1) |
| Duration of curcumin supply, months | 7.9 (0.9-16.6) |
Continuous variables are listed as medians (range), and categorical variables are presented as n (%).
Abbreviations: BMI, body mass index; ASA, American Society of Anesthesiologist.
a
Among 32 synchronous metastatic patients.